Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
David Amsellem is an analyst at Piper Sandler. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/07/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/03/2024 | PCRX | Buy Now | Pacira BioSciences | $20.60 | 103.88% | $42 → $42 | Maintains | Overweight | Get Alert |
| 07/01/2024 | CORT | Buy Now | Corcept Therapeutics | $29.51 | 18.6% | $35 → $35 | Reiterates | Overweight → Overweight | Get Alert |
| 06/27/2024 | AMPH | Buy Now | Amphastar Pharma | $37.37 | 89.99% | $71 → $71 | Reiterates | Overweight → Overweight | Get Alert |
| 05/13/2024 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.36 | 22.25% | $19 → $20 | Reiterates | Overweight → Overweight | Get Alert |
| 05/10/2024 | XERS | Buy Now | Xeris Biopharma Holdings | $2.13 | 40.85% | $4 → $3 | Reiterates | Overweight → Overweight | Get Alert |
| 05/10/2024 | RVNC | Buy Now | Revance Therapeutics | $2.81 | 291.54% | $20 → $11 | Reiterates | Overweight → Overweight | Get Alert |
| 05/10/2024 | COLL | Buy Now | Collegium Pharmaceutical | $31.90 | 22.26% | $39 → $39 | Downgrade | Overweight → Neutral | Get Alert |
| 04/29/2024 | OGN | Buy Now | Organon | $20.14 | 19.17% | $22 → $24 | Maintains | Overweight | Get Alert |
| 04/11/2024 | AQST | Buy Now | Aquestive Therapeutics | $2.41 | 314.94% | → $10 | Initiates | → Overweight | Get Alert |
| 04/01/2024 | ALKS | Buy Now | Alkermes | $24.37 | 60.03% | $39 → $39 | Reiterates | Overweight → Overweight | Get Alert |
| 03/28/2024 | VTRS | Buy Now | Viatris | $10.53 | 23.46% | $11 → $13 | Reiterates | Neutral → Neutral | Get Alert |
| 03/21/2024 | AMRX | Buy Now | Amneal Pharmaceuticals | $6.82 | 17.3% | $6 → $8 | Maintains | Overweight | Get Alert |
| 03/20/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $100.71 | 86.67% | $171 → $188 | Reiterates | Overweight → Overweight | Get Alert |
| 03/05/2024 | AVDL | Buy Now | Avadel Pharmaceuticals | $15.51 | 48.29% | $18 → $23 | Maintains | Overweight | Get Alert |
| 02/29/2024 | RVNC | Buy Now | Revance Therapeutics | $2.81 | 611.9% | $42 → $20 | Maintains | Overweight | Get Alert |
| 02/28/2024 | SUPN | Buy Now | Supernus Pharmaceuticals | $26.24 | 56.25% | $45 → $41 | Maintains | Overweight | Get Alert |
| 02/23/2024 | COLL | Buy Now | Collegium Pharmaceutical | $31.90 | 22.26% | $37 → $39 | Reiterates | Overweight → Overweight | Get Alert |
| 02/16/2024 | ALKS | Buy Now | Alkermes | $24.37 | 60.03% | $35 → $39 | Maintains | Overweight | Get Alert |
| 02/16/2024 | IRWD | Buy Now | Ironwood Pharmaceuticals | $6.57 | 219.63% | $20 → $21 | Maintains | Overweight | Get Alert |
| 02/12/2024 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.36 | 16.14% | $12 → $19 | Upgrade | Neutral → Overweight | Get Alert |
| 01/16/2024 | AXSM | Buy Now | Axsome Therapeutics | $83.62 | 35.14% | $90 → $113 | Maintains | Overweight | Get Alert |
| 01/03/2024 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.36 | -26.65% | $8 → $12 | Upgrade | Underweight → Neutral | Get Alert |
| 12/07/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | $40.59 | 10.86% | $33 → $45 | Downgrade | Overweight → Neutral | Get Alert |
| 11/22/2023 | VTRS | Buy Now | Viatris | $10.53 | 4.46% | $10 → $11 | Maintains | Neutral | Get Alert |
| 11/22/2023 | OGN | Buy Now | Organon | $20.14 | 9.24% | $32 → $22 | Maintains | Overweight | Get Alert |
| 11/14/2023 | CARA | Buy Now | Cara Therapeutics | $0.30 | 235.57% | $12 → $1 | Downgrade | Overweight → Neutral | Get Alert |
| 11/10/2023 | XERS | Buy Now | Xeris Biopharma Holdings | $2.13 | 87.79% | $5 → $4 | Maintains | Overweight | Get Alert |
| 11/09/2023 | SUPN | Buy Now | Supernus Pharmaceuticals | $26.24 | 63.87% | $42 → $43 | Maintains | Overweight | Get Alert |
| 11/09/2023 | RVNC | Buy Now | Revance Therapeutics | $2.81 | 1394.98% | $44 → $42 | Maintains | Overweight | Get Alert |
| 11/03/2023 | PCRX | Buy Now | Pacira BioSciences | $20.60 | 103.88% | $50 → $42 | Maintains | Overweight | Get Alert |
| 11/01/2023 | NBIX | Buy Now | Neurocrine Biosciences | $142.24 | -29.7% | $95 → $100 | Maintains | Neutral | Get Alert |
| 10/27/2023 | ALKS | Buy Now | Alkermes | $24.37 | 43.62% | $37 → $35 | Maintains | Overweight | Get Alert |
| 10/25/2023 | SUPN | Buy Now | Supernus Pharmaceuticals | $26.24 | 60.06% | $43 → $42 | Maintains | Overweight | Get Alert |
| 10/25/2023 | OGN | Buy Now | Organon | $20.14 | 58.89% | $33 → $32 | Maintains | Overweight | Get Alert |
| 10/16/2023 | HRMY | Buy Now | Harmony Biosciences | $32.54 | 29.07% | $72 → $42 | Maintains | Overweight | Get Alert |
| 09/28/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | $40.59 | -18.7% | → $33 | Initiates | → Overweight | Get Alert |
| 09/20/2023 | RVNC | Buy Now | Revance Therapeutics | $2.81 | 1466.17% | $50 → $44 | Maintains | Overweight | Get Alert |
| 08/11/2023 | OPTN | Buy Now | OptiNose | $1.06 | 183.02% | $4 → $3 | Maintains | Overweight | Get Alert |
| 08/10/2023 | AVDL | Buy Now | Avadel Pharmaceuticals | $15.51 | 16.05% | $13 → $18 | Maintains | Overweight | Get Alert |
| 08/09/2023 | EGRX | Buy Now | Eagle Pharmaceuticals | $6.01 | 182.86% | $26 → $17 | Downgrade | Neutral → Underweight | Get Alert |
| 08/08/2023 | CARA | Buy Now | Cara Therapeutics | $0.30 | 3926.85% | $13 → $12 | Maintains | Overweight | Get Alert |
| 08/08/2023 | AXSM | Buy Now | Axsome Therapeutics | $83.62 | 7.63% | $70 → $90 | Upgrade | Neutral → Overweight | Get Alert |
| 08/07/2023 | AMRX | Buy Now | Amneal Pharmaceuticals | $6.82 | -26.69% | $3 → $5 | Maintains | Overweight | Get Alert |
| 08/03/2023 | CORT | Buy Now | Corcept Therapeutics | $29.51 | 5.05% | $27 → $31 | Maintains | Overweight | Get Alert |
| 08/03/2023 | PCRX | Buy Now | Pacira BioSciences | $20.60 | 142.72% | $60 → $50 | Maintains | Overweight | Get Alert |
| 06/07/2023 | ALKS | Buy Now | Alkermes | $24.37 | 51.83% | $35 → $37 | Maintains | Overweight | Get Alert |
| 05/23/2023 | IRWD | Buy Now | Ironwood Pharmaceuticals | $6.57 | 189.19% | $16 → $19 | Maintains | Overweight | Get Alert |
| 05/15/2023 | PCRX | Buy Now | Pacira BioSciences | $20.60 | 191.26% | → $60 | Maintains | Overweight | Get Alert |
| 05/10/2023 | SUPN | Buy Now | Supernus Pharmaceuticals | $26.24 | 75.3% | $45 → $46 | Maintains | Overweight | Get Alert |
| 05/08/2023 | AMRX | Buy Now | Amneal Pharmaceuticals | $6.82 | -56.01% | $5 → $3 | Maintains | Overweight | Get Alert |
| 04/25/2023 | PCRX | Buy Now | Pacira BioSciences | $20.60 | 200.97% | → $65 | Maintains | Overweight | Get Alert |
| 04/04/2023 | CORT | Buy Now | Corcept Therapeutics | $29.51 | -8.51% | → $27 | Initiates | → Overweight | Get Alert |
| 03/07/2023 | CARA | Buy Now | Cara Therapeutics | $0.30 | 4262.42% | $25 → $13 | Maintains | Overweight | Get Alert |
| 02/07/2023 | NBIX | Buy Now | Neurocrine Biosciences | $142.24 | -33.21% | $103 → $95 | Maintains | Neutral | Get Alert |
| 01/31/2023 | RVNC | Buy Now | Revance Therapeutics | $2.81 | 1323.79% | $29 → $40 | Maintains | Overweight | Get Alert |
| 01/23/2023 | SUPN | Buy Now | Supernus Pharmaceuticals | $26.24 | 79.12% | $40 → $47 | Maintains | Overweight | Get Alert |
| 01/05/2023 | AXSM | Buy Now | Axsome Therapeutics | $83.62 | -10.31% | → $75 | Initiates | → Neutral | Get Alert |
| 01/05/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | → $285 | Initiates | → Overweight | Get Alert |
| 01/04/2023 | HRMY | Buy Now | Harmony Biosciences | $32.54 | 115.12% | $62 → $70 | Maintains | Overweight | Get Alert |
| 12/07/2022 | HZNP | Buy Now | Horizon Therapeutics | — | — | $90 → $110 | Maintains | Overweight | Get Alert |
| 11/23/2022 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.36 | -57.21% | $8 → $7 | Maintains | Underweight | Get Alert |
| 11/08/2022 | VTRS | Buy Now | Viatris | $10.53 | -5.03% | → $10 | Upgrade | Underweight → Neutral | Get Alert |
| 11/03/2022 | ALKS | Buy Now | Alkermes | $24.37 | 23.1% | $26 → $30 | Upgrade | Neutral → Overweight | Get Alert |
| 11/02/2022 | NBIX | Buy Now | Neurocrine Biosciences | $142.24 | -27.59% | $91 → $103 | Maintains | Neutral | Get Alert |
| 10/25/2022 | HZNP | Buy Now | Horizon Therapeutics | — | — | $90 → $88 | Maintains | Overweight | Get Alert |
| 10/25/2022 | AMPH | Buy Now | Amphastar Pharma | $37.37 | 7.04% | $43 → $40 | Maintains | Overweight | Get Alert |
| 09/09/2022 | BHC | Buy Now | Bausch Health Companies | $7.25 | -17.24% | $7 → $6 | Maintains | Neutral | Get Alert |
| 09/06/2022 | OGN | Buy Now | Organon | $20.14 | 68.82% | $37 → $34 | Upgrade | Neutral → Overweight | Get Alert |
| 08/31/2022 | SUPN | Buy Now | Supernus Pharmaceuticals | $26.24 | 44.82% | $33 → $38 | Maintains | Overweight | Get Alert |
| 08/16/2022 | ALKS | Buy Now | Alkermes | $24.37 | 6.69% | → $26 | Initiates | → Neutral | Get Alert |
| 08/04/2022 | PCRX | Buy Now | Pacira BioSciences | $20.60 | 268.93% | $80 → $76 | Maintains | Overweight | Get Alert |
| 07/21/2022 | PCRX | Buy Now | Pacira BioSciences | $20.60 | 288.35% | $84 → $80 | Maintains | Overweight | Get Alert |
| 05/25/2022 | EVFM | Buy Now | Evofem Biosciences | $0.01 | 30203.03% | $3750 → $250 | Maintains | Overweight | Get Alert |
| 05/10/2022 | VTRS | Buy Now | Viatris | $10.53 | -5.03% | → $10 | Downgrade | Neutral → Underweight | Get Alert |
| 05/05/2022 | JAZZ | Buy Now | Jazz Pharmaceuticals | $100.71 | 91.64% | $197 → $193 | Maintains | Overweight | Get Alert |
| 05/04/2022 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.36 | -57.21% | $11 → $7 | Downgrade | Neutral → Underweight | Get Alert |
| 04/22/2022 | IRWD | Buy Now | Ironwood Pharmaceuticals | $6.57 | 143.53% | → $16 | Initiates | → Overweight | Get Alert |
| 04/14/2022 | ATRS | Buy Now | Antares Pharma | — | — | $6 → $5.6 | Downgrade | Overweight → Neutral | Get Alert |
| 03/16/2022 | VTRS | Buy Now | Viatris | $10.53 | -5.03% | $17 → $10 | Maintains | Neutral | Get Alert |
| 03/11/2022 | AMPH | Buy Now | Amphastar Pharma | $37.37 | -6.34% | $28 → $35 | Maintains | Overweight | Get Alert |
| 03/03/2022 | NBIX | Buy Now | Neurocrine Biosciences | $142.24 | -33.91% | $114 → $94 | Downgrade | Overweight → Neutral | Get Alert |
| 03/02/2022 | ENDP | Buy Now | Endo International | — | — | $5 → $3 | Maintains | Neutral | Get Alert |
| 03/02/2022 | JAZZ | Buy Now | Jazz Pharmaceuticals | $100.71 | 95.61% | $209 → $197 | Maintains | Overweight | Get Alert |
| 02/22/2022 | COLL | Buy Now | Collegium Pharmaceutical | $31.90 | 31.66% | $36 → $42 | Maintains | Overweight | Get Alert |
| 02/15/2022 | BDSI | Buy Now | BioDelivery Sciences Intl | — | — | $5 → $5.6 | Downgrade | Overweight → Neutral | Get Alert |
| 01/07/2022 | AMPH | Buy Now | Amphastar Pharma | $37.37 | -25.07% | $21 → $28 | Upgrade | Neutral → Overweight | Get Alert |
